Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
A recent University College London research estimates that 1.6 million adults in England, Wales and Scotland used GLP-1s, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro), between early 2024 and early 2025, to lose weight.
This is a self-pay only program
Patients should be advised to maintain adequate hydration, and renal function should be monitored if they become unwell
It is suitable for those recovering from injuries, managing chronic pain, or aiming to enhance overall well-being
US$ 29.42
US$ 28.60
US$ 26.29
US$ 21.68
US$ 29.72
US$ 26.22
US$ 27.02
